• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAGE基因多态性影响非胰岛素依赖型糖尿病患者发生糖尿病相关微血管性皮肤病的易感性。

Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM.

作者信息

Kanková K, Záhejský J, Márová I, Muzík J, Kuhrová V, Blazková M, Znojil V, Beránek M, Vácha J

机构信息

Department of Pathophysiology, Faculty of Medicine, Masaryk University, Komenského nám. 2, 662 43 Brno, Czech Republic.

出版信息

J Diabetes Complications. 2001 Jul-Aug;15(4):185-92. doi: 10.1016/s1056-8727(00)00135-5.

DOI:10.1016/s1056-8727(00)00135-5
PMID:11457670
Abstract

To examine genetic polymorphism in the complete sequence of the Receptor of Advanced Glycation End products (RAGE) gene and its possible associations with diabetes-associated microvascular dermatoses (DAMD). Further, to analyze the distribution of individual genotype combinations on the particular polymorphic loci in the RAGE gene. A part of the RAGE gene spanning a region from -4 to 3334 bp was analyzed on a set of 45 subjects with non-insulin dependent diabetes mellitus (NIDDM) and parallel DAMD by means of PCR with subsequent heteroduplex and single-strand conformation polymorphism (SSCP) analyses. Allele frequencies and genotype combinations of novel common polymorphisms were determined in an associations study comprising four groups of subjects (n=390). Fourteen novel polymorphisms (R77C, V89V, 718G/T, 1704G/T, 1727A1728ins, H305Q, S307C, 2117A/G, 2184A/G, 2245G/A, 2249A/G, 2741G/A, and 3089ACdel) and one described previously (G82S) were identified. Significant association with microvascular dermatoses (MD) irrespective of NIDDM were found for exon mutation 82S (P= .004, after a correction for the number of comparisons P(corr) < .05) and marginally significant for intron variant 1704T (P= .032, P(corr)> .05). Calculated odds ratios for 82S and 1704T were 4.73 (95% CI, 1.51 to 14.77) and 1.73 (95% CI, 0.93 to 3.22), respectively. Certain individual genotype combinations of G82S, 1704G/T, and 2184A/G were significantly associated with the presence of MD (P= .00647) both in diabetic and non-diabetic study populations. The two novel polymorphisms (1704G/T and 2184A/G) together with the G82S were shown to influence the susceptibility to MD independent of diabetes itself.

摘要

研究晚期糖基化终末产物受体(RAGE)基因完整序列中的基因多态性及其与糖尿病相关微血管皮肤病(DAMD)的可能关联。此外,分析RAGE基因特定多态性位点上个体基因型组合的分布情况。通过聚合酶链反应(PCR),随后进行异源双链和单链构象多态性(SSCP)分析,对45例非胰岛素依赖型糖尿病(NIDDM)合并并行DAMD的患者进行了RAGE基因中一段从-4至3334 bp区域的分析。在一项包含四组受试者(n = 390)的关联研究中确定了新型常见多态性的等位基因频率和基因型组合。共鉴定出14种新型多态性(R77C、V89V、718G/T、1704G/T、1727A1728ins、H305Q、S307C、2117A/G、2184A/G、2245G/A、2249A/G、2741G/A和3089ACdel)以及一种先前描述过的多态性(G82S)。发现外显子突变82S与微血管皮肤病(MD)显著相关,无论是否患有NIDDM(P = 0.004,经比较次数校正后P(corr) < 0.05),内含子变体1704T具有边缘显著性(P = 0.032,P(corr)> 0.05)。82S和1704T的计算比值比分别为4.73(95%可信区间,1.51至14.77)和1.73(95%可信区间,0.93至3.22)。在糖尿病和非糖尿病研究人群中,G82S、1704G/T和2184A/G的某些个体基因型组合与MD的存在显著相关(P = 0.00647)。已证明两种新型多态性(1704G/T和2184A/G)与G82S一起,独立于糖尿病本身影响对MD的易感性。

相似文献

1
Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM.RAGE基因多态性影响非胰岛素依赖型糖尿病患者发生糖尿病相关微血管性皮肤病的易感性。
J Diabetes Complications. 2001 Jul-Aug;15(4):185-92. doi: 10.1016/s1056-8727(00)00135-5.
2
Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status.
Metabolism. 2001 Oct;50(10):1152-60. doi: 10.1053/meta.2001.26757.
3
Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes.RAGE基因中G82S多态性与2型糖尿病皮肤并发症的关联
Diabetes Care. 1999 Oct;22(10):1745. doi: 10.2337/diacare.22.10.1745b.
4
Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.中国人群中晚期糖基化终末产物受体基因1704G/T和G82S多态性与糖尿病视网膜病变的相关性
J Endocrinol Invest. 2009 Mar;32(3):258-62. doi: 10.1007/BF03346463.
5
Polymorphisms 1704G/T, 2184A/G, and 2245G/A in the rage gene are not associated with diabetic retinopathy in NIDDM: pilot study.愤怒基因中的多态性1704G/T、2184A/G和2245G/A与非胰岛素依赖型糖尿病患者的糖尿病视网膜病变无关:初步研究。
Retina. 2002 Feb;22(1):119-21. doi: 10.1097/00006982-200202000-00026.
6
Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis.斑块状银屑病中晚期糖基化终末产物受体(RAGE)的基因多态性(G82S、1704G/T、2184A/G和2245G/A)
Arch Dermatol Res. 2002 May;294(3):127-30. doi: 10.1007/s00403-002-0301-7. Epub 2002 Apr 9.
7
Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus.RAGE基因的单倍型分析:2型糖尿病患者糖尿病肾病单倍型标志物的鉴定
Nephrol Dial Transplant. 2005 Jun;20(6):1093-102. doi: 10.1093/ndt/gfh711. Epub 2005 Mar 24.
8
Distribution of the receptor for advanced glycation end products gene polymorphisms in patients with chronic periodontitis: a preliminary study.晚期糖基化终末产物受体基因多态性在慢性牙周炎患者中的分布:一项初步研究。
J Periodontol. 2001 Dec;72(12):1742-6. doi: 10.1902/jop.2001.72.12.1742.
9
Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population.受体晚期糖基化终产物基因多态性及循环 RAGE 水平与中国人糖尿病视网膜病变的相关性。
J Diabetes Res. 2013;2013:264579. doi: 10.1155/2013/264579. Epub 2013 Nov 4.
10
Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease.马来西亚慢性肾病患者晚期糖基化终末产物受体(RAGE)基因多态性的关联研究
PeerJ. 2016 Apr 18;4:e1908. doi: 10.7717/peerj.1908. eCollection 2016.

引用本文的文献

1
Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases.晚期糖基化终末产物受体(RAGE)与氧化应激在炎症性和感染性皮肤病中的作用
Antioxidants (Basel). 2021 Jan 9;10(1):82. doi: 10.3390/antiox10010082.
2
Association of vascular endothelial growth factor -634G/C and receptor for advanced glycation end products G82S gene polymorphisms with diabetic retinopathy.血管内皮生长因子-634G/C和晚期糖基化终末产物受体G82S基因多态性与糖尿病视网膜病变的关联
Int J Ophthalmol. 2016 Aug 18;9(8):1106-11. doi: 10.18240/ijo.2016.08.04. eCollection 2016.
3
Polymorphism 2184A/G in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetes.
AGER基因中的2184A/G多态性与2型糖尿病汉族患者的糖尿病视网膜病变无关。
J Int Med Res. 2016 Jun;44(3):520-8. doi: 10.1177/0300060516638990. Epub 2016 Mar 31.
4
Association of 2184AG Polymorphism in the RAGE Gene with Diabetic Nephropathy in Chinese Patients with Type 2 Diabetes.中国 2 型糖尿病患者中 RAGE 基因 2184AG 多态性与糖尿病肾病的相关性
J Diabetes Res. 2015;2015:310237. doi: 10.1155/2015/310237. Epub 2015 Dec 3.
5
Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population.受体晚期糖基化终产物基因多态性及循环 RAGE 水平与中国人糖尿病视网膜病变的相关性。
J Diabetes Res. 2013;2013:264579. doi: 10.1155/2013/264579. Epub 2013 Nov 4.
6
2245G/A polymorphism of the receptor for advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malaysian population.2245G/A 多态性受体的先进糖基化终产物(RAGE)基因与马来西亚人口的糖尿病视网膜病变有关。
Br J Ophthalmol. 2012 Feb;96(2):289-92. doi: 10.1136/bjophthalmol-2011-300658. Epub 2011 Nov 24.
7
Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?怒基因 GLY82 丝氨酸多态性与土耳其糖尿病和非糖尿病合并冠心病患者之间是否存在关联?
Mol Biol Rep. 2012 Apr;39(4):4423-8. doi: 10.1007/s11033-011-1230-3. Epub 2011 Sep 25.
8
Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.中国人群中晚期糖基化终末产物受体基因1704G/T和G82S多态性与糖尿病视网膜病变的相关性
J Endocrinol Invest. 2009 Mar;32(3):258-62. doi: 10.1007/BF03346463.
9
RAGE: a novel target for drug intervention in diabetic vascular disease.RAGE:糖尿病血管疾病药物干预的新靶点。
Pharm Res. 2004 Jul;21(7):1079-86. doi: 10.1023/b:pham.0000032992.75423.9b.